Sweeteners
acesulfame-K causes genotoxicity
Part of: • acesulfame-K
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Despite recurring suspicion, high-quality toxicology finds no credible genotoxic or carcinogenic signal for acesulfame-K, and regulators (JECFA/EFSA/FDA) hold it safe at normal intakes. The main dissent is the NutriNet-Santé cohort's weak association of Ace-K with cancer risk — observational and unreplicated. Net: not supported as genotoxic.
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Yan et al. 2022 · Nutrients | meta-analysis | tested-null | low | MA: ace-K subgroup among sweeteners with a weak Europe-only cancer signal; overall null. |
| Marchitti et al. 2025 · Adv Nutr | meta-analysis | contradicts | high | Review of animal + mechanistic evidence: no genotoxic or carcinogenic potential for acesulfame-K (or other NSS except the human-irrelevant saccharin rat effect). |
| Buchner EM et al 2019 · study_type: in-vitro | in-vitro | mixed | moderate | Acesulfame ozonation products tested in micronucleus, umu, Ames-fluctuation, and comet assays: acesulfame solutions in ultrapure water showed genotoxic effects after ozonation, but the isolated/crystallized major transformation product (OP1 |
| Li et al. 2024 · Br J Nutr | meta-analysis | contradicts | moderate | MA: non-nutritive sweeteners (incl. ace-K) not associated with endometrial cancer. |
| EFSA Panel on Food Additives and Flavourings (FAF) et al 2025 · study_type: observational | animal | contradicts | high | EFSA's 2025 re-evaluation of acesulfame K (E950) as a food additive concluded 'no safety concerns arise for genotoxicity of acesulfame K and its degradation products,' based on synthesis of systematically appraised human and animal studies; |
| Shankar N et al 2026 · study_type: animal | animal | supports | moderate | Drosophila SMART assay found dose-dependent genotoxic effects (10/30/50 mM) for Ace-K alone and in binary/ternary combos with aspartame and stevia; Ace-K-containing mixtures showed higher spot frequencies at the lowest dose (10 mM), and in- |
| Pavanello et al. 2023 · Regul Toxicol Pharmacol | observational | contradicts | moderate | Tox + epi review: no evidence of cancer risk associated with acesulfame-K. |
| Haighton et al. 2019 · Regul Toxicol Pharmacol | observational | contradicts | moderate | Quality-appraised epidemiology: no support for ace-K increasing cancer risk. |
| Zhu et al. 2024 · Med Princ Pract | meta-analysis | contradicts | moderate | MA: artificial sweeteners not associated with higher colorectal cancer. |
| Okus F et al 2024 · study_type: mechanism | mechanism | supports | low | Molecular docking of acesulfame potassium (ACE-K) against ATM and p53 (DNA-damage-response proteins) and DNA itself, framed around prior lab findings of genotoxic effects of ACE-K; docking scores reported for other additives but ACE-K inclu |
| Debras et al. 2022 · PLoS Med | observational | tested-null | moderate | NutriNet-Santé cohort: acesulfame-K intake weakly associated with higher overall cancer risk (observational). |
| Arulanandam CD et al 2025 · study_type: mechanism | mechanism | supports | low | In silico mutagenicity/carcinogenicity prediction (LAZAR, pKCSM, Toxtree) of 16 sugar substitutes identified four compounds, including 'Ace' (acesulfame), as predicted mutagens. |
| Xie et al. 2024 · J Transl Med | mechanism | tested-null | low | Integrative analysis of artificial sweeteners and cancer: associations inconsistent across sweeteners/sites. |
| Boon D et al 2025 · study_type: meta-analysis | observational | contradicts | moderate | Systematic review of 90 epidemiology studies (incl. ace-K) and 17 cancer types found no consistent NSS-cancer associations and no dose-response; states experimental animal and mechanistic evidence 'does not support human-relevant carcinogen |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.